Shuttle Pharmaceuticals appoints Christopher Cooper as interim Co-CEO

Shuttle Pharmaceuticals (SHPH) Holdings announced the appointment of Christopher Cooper as interim Co-CEO focused on enhancing the Company’s capital markets and business capabilities. Anatoly Dritschilo, Chairman of the Company’s Board of Directors, will continue in his role as Co-CEO overseeing the Company’s scientific and clinical trial activities. Cooper has more than 27 years of experience in management and finance, having worked in the oil and gas, telecommunications and technology industries. In addition to his appointment as Interim Co-CEO of the Shuttle Pharma, Cooper also serves as President, CEO and Founder of First Towers & Fiber, a telecommunications infrastructure company with operations in Latin America, positions he has held since 2017. From 2010 until 2017, Cooper served as President and CEO of Aroway Energy, a Vancouver, British Columbia-based oil and gas company, where he was responsible for overseeing day to day operations, financial reporting, and oversaw acquisitions and debt and equity financing.